Reply: The clinical and economic benefits of capecitabine and tegafur with uracil in metastatic colorectal cancer

Documenti analoghi

• The clinical and economic benefits of capecitabine and tegafur with uracil in metastatic colorectal cancer
  di: Almond, J, et al.
  Pubblicazione: (2007)
• The clinical and economic benefits of capecitabine and tegafur with uracil in metastatic colorectal cancer
  di: Ward, S E, et al.
  Pubblicazione: (2006)
• Reply: Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer
  di: Ohwada, S, et al.
  Pubblicazione: (2004)
• Reply: Capecitabine and mitomycin C in patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan
  di: Chong, G, et al.
  Pubblicazione: (2006)
• Reply: Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer
  di: Feliu, J, et al.
  Pubblicazione: (2011)